0001127602-20-010513.txt : 20200312
0001127602-20-010513.hdr.sgml : 20200312
20200312201839
ACCESSION NUMBER: 0001127602-20-010513
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200310
FILED AS OF DATE: 20200312
DATE AS OF CHANGE: 20200312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Day Daniel Patrick
CENTRAL INDEX KEY: 0001638643
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 20710416
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DRIVE
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES INC
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-03-10
0000882095
GILEAD SCIENCES INC
GILD
0001638643
O'Day Daniel Patrick
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
1
Chairman & CEO
Non-qualified Stock Option (Right to Buy)
72.34
2020-03-10
4
A
0
256620
0
A
2030-03-10
Common Stock
256620
256620
D
Restricted Stock Unit
2020-03-10
4
A
0
43200
A
Common Stock
43200
163132
D
The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
/s/ Amy Kim by Power of Attorney for Daniel O'Day
2020-03-12